GSK raises $1B+ from selling shares in consumer health spinoff Haleon
GSK is selling off part of its stake in its consumer health spinoff Haleon, raising gross proceeds of approximately $1 billion (£804 million), the company said Friday.
The consumer health giant that is now Haleon was created when GSK and Pfizer merged their consumer healthcare businesses in 2019, and it was spun off and listed on the London stock exchange in 2022.
The British drugmaker agreed to sell 240 million shares of Haleon for 335 pence per share. Once the sale is done, GSK will hold about 955 million ordinary shares in Haleon, approximately 10.3%.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.